Issue of Equity

Issue of Equity

Eco Animal Health Group Plc

ECO Animal Health Group plc

(“Eco” or the “Company”)

28 November 2013

The Company has been informed that an ex-employee has exercised options to purchase 10,000 new shares of 5p each in the Company at an exercise price of 8500 at £0.85 per share and 1,500 at £1.085 per share.

Application has been made for the 10,000 new Ordinary Shares to be admitted to trading on the Alternative Investment Market (“AIM”)of London Stock Exchange plc. Admission of the new Ordinary Shares is expected to become effective on 6 December 2013.

Following the issue of the new Ordinary Shares, the Company’s total issued share capital with voting rights and which is admitted to trading on AIM will consist of 62,460,931 ordinary shares of 5p each, with one voting right per share.

Enquiries	Â
Eco Animal Health Group plc
Peter Lawrence, Executive Chairman		020 8336 6190

Spiro Financial	Â
Anthony Spiro		020 8336 6196
			Â
			Â
Cenkos Securities plc (Nominated adviser)
Stephen Keys		020 7397 8926
Elizabeth Bowman		020 7397 8928

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.